iSpecimen Inc. Comprehensive Income
iSpecimen Inc. (ISPC) reported Comprehensive Income of -$10.49 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-04-01
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$5.00M.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$2.78M.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$1.05M.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$1.66M.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$10.49M.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$12.50M.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$11.10M.
- iSpecimen Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$10.25M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$7.78M derived: sum of 2 quarters · filed 2026-04-01 | -$8.83M derived: sum of 3 quarters · filed 2026-04-01 | -$10.49M 10-K · filed 2026-04-01 |
| 2025-09-30 | -$2.78M 10-Q · filed 2025-11-17 | -$3.83M derived: sum of 2 quarters · filed 2025-11-17 | -$5.49M 10-Q · filed 2025-11-17 | -$11.53M derived: sum of 4 quarters · filed 2026-04-01 |
| 2025-06-30 | -$1.05M 10-Q · filed 2025-08-14 | -$2.71M 10-Q · filed 2025-08-14 | -$8.75M derived: sum of 3 quarters · filed 2026-04-01 | -$10.19M derived: sum of 4 quarters · filed 2026-04-01 |
| 2025-03-31 | -$1.66M 10-Q · filed 2025-05-19 | -$7.71M derived: sum of 2 quarters · filed 2026-04-01 | -$9.15M derived: sum of 3 quarters · filed 2026-04-01 | -$11.25M derived: sum of 4 quarters · filed 2026-04-01 |
| 2024-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$7.49M derived: sum of 2 quarters · filed 2026-04-01 | -$9.60M derived: sum of 3 quarters · filed 2026-04-01 | -$12.50M 10-K · filed 2026-04-01 |
| 2024-09-30 | -$1.44M 10-Q · filed 2025-11-17 | -$3.55M derived: sum of 2 quarters · filed 2025-11-17 | -$6.45M 10-Q · filed 2025-11-17 | -$9.52M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$2.11M 10-Q · filed 2025-08-14 | -$5.01M 10-Q · filed 2025-08-14 | -$8.08M derived: sum of 3 quarters · filed 2025-08-14 | -$10.20M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.90M 10-Q · filed 2025-05-19 | -$5.98M derived: sum of 2 quarters · filed 2025-05-19 | -$8.09M derived: sum of 3 quarters · filed 2025-05-19 | -$11.59M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | -$5.18M derived: sum of 2 quarters · filed 2025-04-14 | -$8.69M derived: sum of 3 quarters · filed 2025-04-14 | -$11.10M 10-K · filed 2025-04-14 |
| 2023-09-30 | -$2.11M 10-Q · filed 2024-11-07 | -$5.61M derived: sum of 2 quarters · filed 2024-11-07 | -$8.03M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$3.50M 10-Q · filed 2024-08-06 | -$5.91M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$2.41M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$10.25M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |